Brief: Shield Therapeutics Says On Track To Turn Cash Flow Positive By End 2025
23/07/2025 07:25
July 23 (Reuters) - Shield Therapeutics PLC STXS.L: SHIELD THERAPEUTICS - Q2 2025 TRADING UPDATE SHIELD THERAPEUTICS PLC - ON TRACK TO TURN CASH FLOW POSITIVE BY END 2025 Source text: ID:nRSW2109Sa Further company coverage: STXS.L ((( Reuters.Briefs@thomsonreuters.com );))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update